Health / BioPharma / Daily / Pharma / SYN / Top Story / biopharma nl / California / Clinical Trials / Cystic fibrosis / dallas / deals / investing / lung disease / menlo park / ReCode Therapeutics / Startups

ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs

Posted on: Oct 22, 2021   |   Posted by: Care Mag

ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs

ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup's technology uses lipid nanoparticles to deliver...

Continue reading ...